Video: Colon Cancer Survivor and Endoscopy Technician Urges People to Get Screened

by


Second chances aren’t a given, which is why Keith Lyons is determined to make the most of his.

“I’m a survivor. I got a second chance at life, and I’m not going to sit on it,” said Keith, an endoscopy technician at the Endoscopy Center of Red Bank, an AMSURG-affiliated ambulatory surgery center in New Jersey.

He is committed to helping others survive. In addition to raising awareness, he supports physicians in detecting and preventing colorectal cancer through colonoscopies at work.

As a teenager, he had an inflammatory bowel disease and didn’t like the thought of having to receive additional colonoscopies. Then, at 32, with the help of a trusted nurse and knowing the importance of his gastrointestinal health, he decided to get screened. That’s when he learned of his Stage 3 colon cancer diagnosis, which he has worked to overcome.

“It’s an everyday fight. I’m not going to lie. But I’m still here to fight because I chose to get myself checked out.”

Now 55, Keith continues to spread his message of survival, encouraging people to get screened and using his experience to break stigmas around colonoscopies.

“‘Colon cancer is preventable.’ That’s my slogan,” he said. “Please get checked.”

Celebrating Black History Month

by


Legacy, love, inspiration and leadership – these are some of the many meanings of Black history. From learning the achievements of Black trailblazers and honoring their families’ culture to uplifting the next generation, our teammates talk about the many ways they celebrate Black History Month and the stories of Black people.

Black history is American history and during February and beyond, we encourage everyone to reflect on the different experiences of our community members and how we can all work to create a more supportive, inclusive and just society.

In the Eye of the Storm

by

When hurricanes happen, our thoughts first go to our teammates and partners in the path of the storm. Are they safe? Do they have the resources and support they need? But more than that, as a medical group, we have an obligation to the patients and communities we serve.

In preparation for Hurricane Ian, Envision leaders stood up the Incident Response Task Force, led by Dr. Brian Baxter, President of Alliance National Group, and Dr. Christopher Scott, Senior Vice President for HCA West Florida Region. “We have been doing hurricane response for years and have a good process in place for Florida, but Mother Nature gave us a break over the last three years. So, when hurricane season approached, we knew that we had to get ready,” Dr. Baxter said.

Sky Falls at Hospital in Port Charlotte

“No one anticipated the hurricane to turn toward Fawcett,” said Dr. Ali Vaziri, Hospital Medicine Site Medical Director for Fawcett Memorial Hospital.

In the days leading up to Hurricane Ian’s arrival, the team had been preparing for the storm, but all projections showed the storm moving north toward Tampa. However, on Tuesday, Oct. 4 the winds shifted, and the team braced for the Category 4 hurricane’s impact.

Dr. Alaina Hunt, Emergency Medicine Site Medical Director for Fawcett Memorial Hospital, was on point in the emergency department that day. “We knew from Hurricane Charlie that the ER flooded, so our team started by moving the ER up to the PACU, making a makeshift ER up there.”

Meanwhile, in the ICU, Envision hospitalists Dr. Michael Stagg and Dr. Elise Lambird were holding down the fort. The ICU is located on the fourth floor, making what that team did even more impressive, Dr. Vaziri says. “The roof of the ICU came off. Water started to collect and then started trickling down to floors below, causing the elevators to short out.”

Dr. Hunt and her team immediately jumped into action. “I immediately started assigning teammates to figure out where we could mobilize patients,” she said. “Our team started waking up and moving patients out of the ICU. Some patients were intubated and had to be manually bagged for transport.”

“One by one, the team carried patients down to floors below; wherever they could find a bed or a safe place to put them,” Dr. Vaziri said. “Truly heroic.”

At this point, the team began evacuating patients. Around 1,000 patients were evacuated from Lee County. Envision teammates at a different hospital in Brooksville took in several med-surg patients. Amy Nixon, DCI, Dr. Eric Sladek and Dr. Monicka Felix coordinated with the resident team to ensure patients were evacuated safely.

Scoping Out AMSURG Needs

Gulf Coast Endoscopy Center South, an AMSURG partner center in Fort Myers, was not immune to the storm’s devastating impact.

Teammates preparing supplies

“This team has truly stuck together through some of the worst times of their lives,” said AMSURG Director of Operations Alex Blair.

On Tuesday, Oct. 4, Blair loaded a truck with supplies and headed to the ambulatory surgery center. Nearing the facility, Blair said she encountered a city that looked more like a war zone than a thriving tourist town, with debris piled on the shoulders of roads, non-functioning traffic lights and National Guard members at intersections guiding traffic.

As Blair and the Gulf Coast Endoscopy Center South team have demonstrated, recovery isn’t measured by what you put back up. The recovery process begins as soon as people come together to bring hope to survivors.

“I was encouraged to see how they stuck together when they themselves are struggling through the hurricane aftermath,” Blair said. “They prevailed. Safe. And together.”

Radiating Hope

As stories rolled in from teammates across the state, Radiology Services’ Chief Clinical Officer Dr. David Dascal and Senior Vice President Dr. Roi Bittane jumped into action.

Dr. Dascal (left) and Dr. Bittane (right) loading up supplies

“We had called all our radiology teammates in the area where Hurricane Ian had made landfall,” said Dr. Dascal. “A few responded, saying they were in need of assistance. For some, it was help getting off shift – one physician had been at the hospital for three days. Others needed supplies.”

It was Roi’s idea to deliver the supplies. “We made a list of the needs we were hearing from people and loaded up.”

The duo arrived in Port Charlotte and Sarasota with resources like generators, gas, water and canned foods and a ready willingness to lend a hand.

“We realized quickly that we were going to have to get creative to get to everyone,” Dr. Dascal said. “Roi is the military guy, so he had a tow rope and all kinds of other gadgets to help. I was in good hands.”

Road conditions in Southwest Florida on Oct. 4

Throughout the day, they traveled to any teammate they could reach, providing supplies, support and a friendly face. Dr. Dascal reflected on the state of his team. “They were all so happy to see us, but they were struggling.”

Thank You From Dr. Baxter, Dr. Scott and Envision

“I really just want to say, ‘thank you,’” Dr. Baxter said. “The collaboration across teams was incredible. Everyone worked together. Everyone was focused on doing what was best for patients and each other. No one complained or asked why. When things got hairy, they jumped right in. And that sentiment has been echoed all over by both Envision leaders and our hospital partners.”

“I am most proud of the teamwork and comradery that was displayed,” Dr. Scott said. “Everyone came together. Providers stepped up to help each other and ensure patients were safe. It’s one thing to be a company, but when we start to think of each other as family, it takes a whole different slant.”

At Envision, caring deeply for each other is core to what we do and who we are. No matter someone’s role, the city in which they live or their proximity to the bedside, we each are here to make a difference. As devastating as events like Hurricane Ian can be, they also can bring out the best in people and unite us as a team and a community.

Actors “Lead From Behind” With Colonoscopy Screenings.

by

A simple bet between friends — and colonoscopy screenings — may have saved the lives of actors Ryan Reynolds and Rob McElhenney.

The co-owners of the Wrexham Association Football Club in Wales made a friendly wager, which Reynolds ultimately lost. McElhenney bet that if he learned to speak Welsh, Reynolds would publicly broadcast his first colonoscopy to raise awareness regarding colon cancer.

The actors’ screening video launched the Lead From Behind campaign in partnership with the Colorectal Cancer Alliance (CCA). The campaign’s focus is to “help people learn that colon cancer is ‘The Preventable Cancer’” through timely screenings.

Research shows more young people are getting colon cancer. Now, leading healthcare agencies recommend screenings begin at 45 for those at average risk.

Both Reynolds (Deadpool) and McElhenney (It’s Always Sunny in Philadelphia) are 45.

“Part of being this age is getting a colonoscopy,” Reynolds said in the video. “It’s a simple step that could literally — I mean literally — save your life.”

Colonoscopy Saves Lives.

Colorectal cancer is the second-deadliest cancer in the US. But it doesn’t have to be. This type of cancer is preventable through timely screenings.

Colonoscopy is the only screening method that can both detect and prevent colorectal cancer. The disease often begins as a growth, called a polyp, inside the colon or rectum. Through a colonoscopy, polyps can be both detected and removed before they become cancerous.

Reynolds underwent his colonoscopy first. Following the procedure, Dr. Jonathan LaPook, his gastroenterologist, praised Reynolds’ thorough bowel prep. This preparation helped LaPook find and remove an “extremely subtle polyp” on the right side of Reynolds’ colon.

“This was potentially lifesaving for you,” LaPook said. “This is exactly why you do this.”

Later, Dr. Leo Treyzon, also a gastroenterologist, told McElhenney he found three polyps during his colonoscopy.

“They were small,” Dr. Treyzon said. “They were not a big deal, but [it was] certainly a good idea that we found them and removed them.”

The doctors recommended the actors repeat the colonoscopy in a couple of years.

Young People Are at Risk.

The CCA reports one in 24 people gets colon cancer. Colorectal cancer is not just a disease of the elderly. One in 260 people will get colon cancer before they turn 50. This is called early-onset or young-onset cancer.

Research indicates that people who are diagnosed when younger than 50 are more likely to have advanced disease at diagnosis.

For these reasons, screenings should begin at 45 for those at average risk of developing colorectal cancer. Individuals should be screened even if they don’t have symptoms. People with digestive symptoms should be considered for colonoscopy regardless of age.

Don’t Delay Your Screening.

By 2030, colon cancer is predicted to be the top cancer killer for people younger than 50, according to the CCA.

If you are 45 or older, don’t delay your colorectal cancer screening. The five-year survival rate is about 90 percent when found at an early stage before it has spread to other organs.

The Affordable Care Act requires most private insurance to cover the costs of colorectal cancer screening tests. Plans vary, so it’s important to contact your healthcare provider to verify your coverage.

If you do not have insurance, there are resources to learn about a low-cost or free colonoscopy. Some resources include the CCA Helpline, ColonoscopyAssist™ or your state’s health and human services or department of health.

A colon cancer screening may save your life or the life of a loved one. Our doctors perform colonoscopy screenings at surgery centers around the country. Search for a gastroenterologist in your area and schedule a colonoscopy.

AMSURG Celebrates Its 30th Anniversary

by

 

AMSURG launched in 1992 as a pioneer in the ambulatory surgery center industry, originating a physician partnership model that endures today. Our original focus was endoscopy centers, but we quickly expanded to include ophthalmology, orthopedic and multi-specialty centers. Today, AMSURG is an industry innovator, advocate, and source for patients to find quality care in their communities.

AMSURG has grown from six partner physician groups in 1992 into a network of nearly 2,000 partner physicians at more than 255 facilities in 34 states and the District of Columbia. But our mission has never changed – to provide quality care when and where it’s needed most, providing enhanced access to services that improve and lengthen life.

Over the past three decades, AMSURG partner physicians have performed more than 25 million procedures across multiple specialties. What began with endoscopies has evolved to incorporate everything from eye care and pain management to the latest in orthopedic care, including total joint replacements – all in a same-day outpatient setting.

One of our proudest achievements came a dozen years ago when we launched StopColonCancerNow, a network of gastroenterologists that spans 32 states and the District of Columbia. Through their work with patients and public awareness and education campaigns, these clinicians combat the second deadliest form of cancer, colon cancer. AMSURG itself is a nation’s leading operator of GI endoscopy centers, and we provide cutting-edge research with Mount Sinai Health Systems and other partners to reduce health disparities and encourage more Americans to get screened for colon cancer earlier.

Advocacy and education are integral to how we serve patients. In 2012, we launched YourSightMatters, a campaign to raise awareness about cataracts and eye health. Today this coalition represents 300 ophthalmologists, optometrists, nurses, and staff at 50 surgery centers.

AMSURG was publicly traded on NASDAQ from 1997 until the merger with Envision Healthcare. Revenues first topped $100 million in 1999. In 2000, AMSURG was named to Forbes’ list of Best Small Companies, which features the country’s most rapidly growing firms. The growth continued:

  • By 2002, AMSURG was a partner to 100 surgery centers, and by 2006 we were the largest ASC provider by the number of centers.
  • In 2007, AMSURG launched a multi-specialty ASC acquisition strategy. Today, we have 58 multi-specialty centers averaging more than 350,000 procedures a year.
  • By 2008, our partners were performing one million procedures annually.
  • In 2012, AMSURG established a health system partnership strategy, and today we have 57 centers with health system partners.

That year, we also finalized a partnership with RWJBarnabas Health to offer New Jersey area patients enhanced access to outpatient surgery services.

AMSURG merged with Sheridan Healthcare in 2014 and Envision Healthcare in 2016. That partnership enables us to make care more affordable and accessible to patients, champion wellness, and empower clinicians to improve the health of the communities they serve.

AMSURG Sees Increase in Colorectal Cancer, Urges Americans to Receive Timely Screenings

by

NASHVILLE, Tenn. — AMSURG, a division of Envision Healthcare and a national leader in gastrointestinal care, is seeing an increase in colorectal cancer diagnoses and encouraging Americans to receive timely, appropriate screenings and not delay care.

AMSURG data reveals that, in 2021, there was a measurable increase in advanced stage colorectal cancer and precancerous growths, called polyps, in adults of all ages compared to 2020. This increase might be due to patients delaying screenings and care during the COVID-19 pandemic. In 2020, AMSURG reported more than 200,000 patients had missed their colonoscopies since the start of the pandemic.

“Any increase in colorectal cancer is very concerning,” said Regina DeHart, colon cancer survivor and Vice President at AMSURG. “Having been diagnosed with colon cancer at 42, I know how important it is to have timely screenings. If the pre-cancerous or cancerous polyps are removed in time, there is a greater chance of surviving. Any delay in routine screenings – even by a year – can make a difference in saving someone’s life. People can thrive after a CRC diagnosis, but timing matters.”

Although colorectal cancer is the second leading cause of cancer death in the U.S., it is one of the most preventable cancers. As a leader in CRC screening, detection and prevention, AMSURG has been educating the public about the importance of timely screenings based on an individual’s age and risk factors. De-identified data from nearly 3 million colonoscopies performed at AMSURG ambulatory surgery centers supports recent recommendations to lower the first-time screening age from 50 to 45 for people at average risk.

Based on 2021 AMSURG data, people were on average 57.6 years old when they had their first screening colonoscopy. In 2016, the average person receiving a first-time screening was 58.5 years old – which was before the American Cancer Society and the U.S. Preventative Services Task Force released guidance changing the age to 45.

“While the U.S. healthcare system has made progress in lowering the recommended screening age, too many people are starting their screenings too late. A lot of work remains to educate people and encourage them to begin screening at 45,” said John Popp, MD, Medical Director for AMSURG. “Receiving timely and routine colonoscopies can save your life. If you are 45 or older, you should be screened. If you have a family history of colorectal cancer or are experiencing symptoms, such as altered bowel habits or blood in the stool, talk to your physician about a colonoscopy regardless of your age. In addition, a positive at-home test should be evaluated with a follow-up colonoscopy promptly. When a colonoscopy is delayed – especially after a positive at-home test – there is a greater chance an individual will have more advanced cancer.”

A colonoscopy is the most thorough screening test. It enables physicians to examine the entire length of the colon to identify and remove polyps before they pose a greater health risk to patients. Individuals should consult a physician if they are experiencing any signs or symptoms or have questions about when they should be screened.

To learn more about colorectal cancer or where to schedule a colonoscopy, visit StopColonCancerNow.com.

###

About AMSURG
AMSURG acquires, develops and operates ambulatory surgery centers (ASC) in partnership with physicians throughout the United States. As of January 1, 2021, AMSURG operates and holds ownership in more than 250 ASCs in 34 states and the District of Columbia with medical specialties ranging from gastroenterology to ophthalmology and orthopedics. To learn more about AMSURG, a division of Envision Healthcare Corporation, visit www.amsurg.com.

About Envision Healthcare Corporation
Envision Healthcare Corporation is a leading national medical group that delivers physician and advanced practice provider services, primarily in the areas of emergency and hospitalist medicine, anesthesiology, radiology/teleradiology, and neonatology to more than 1,800 clinical departments in healthcare facilities in 45 states and the District of Columbia. Post-acute care is delivered through an array of clinical professionals and integrated technologies which, when combined, contribute to efficient and effective population health management strategies. As a leader in ambulatory surgical care, AMSURG holds ownership in more than 250 surgery centers in 34 states and the District of Columbia, with medical specialties ranging from gastroenterology to ophthalmology and orthopedics. In total, the medical group offers a differentiated suite of clinical solutions on a national scale with a local understanding of our communities, creating value for health systems, payers, providers, and patients. For additional information, visit www.envisionhealth.com.

Need a Gastroenterologist? Look Past Average

by

The U.S. Preventive Services Task Force, an independent panel of primary care and prevention experts, recently issued new guidelines that recommend individuals of average risk begin colorectal cancer (CRC) screenings at age 45 instead of age 50.

The Task Force said its recommendation was prompted by an increase in the CRC rate in younger people. Colorectal cancer is the second leading cause of U.S. cancer death, and more than 10 percent of all new CRC cases are diagnosed in patients under age 50.

While colorectal cancer screenings are essential, clinicians and patients should understand that not all colonoscopies are equal. In particular, to ensure they receive quality care, before scheduling an appointment, patients should ask their gastroenterologist about the gastroenterologist’s adenoma detection rate (ADR) – a measurement that indicates how often precancerous polyps are found during exams and that contributes to how carefully colonoscopies are performed.

A study by the Polish Ministry of Health recently published in the Annals of Internal Medicine separated colonoscopies into high- and low- quality exams, with a 20 percent ADR as the dividing line. The goal for the GI Quality Improvement Consortium (GIQuIC), which sets the standard in the collection and reporting of quality measures for the practice of gastrointestinal endoscopy, is a 25 percent ADR. The study, the first to include baseline examination quality in the analysis of long-term risk for CRC and mortality after a negative colonoscopy, also defined high-quality colonoscopies as those that include cecal intubation (a term that means the entire colon was examined) and adequate bowel preparation.

The Polish researchers found patients who received just one negative colonoscopy were at a lower risk for colorectal cancer for up to 17.4 years – but only if the patient had a high-quality exam. The study concluded colonoscopies with ADRs higher than 20 percent “provided a profound and stable reduction in both CRC incidence and mortality throughout follow-up.” In other words, if the negative screening came from a clinician with an ADR below 20 percent, future CRC risk was higher.

Specifically, the researchers found high-quality exams resulted in a two-fold reduction in the colorectal cancer incidence rate and a two-fold lower mortality rate. With a low-quality colonoscopy, mortality already was significantly higher the first five years after examination. The researchers determined, “Many cases of CRC arise from lesions missed at baseline examination rather than from newly developed lesions.”

An analysis of U.S. patients by Kaiser Permanente in 2014 resulted in similar findings. Specifically, Kaiser found for each one percent increase in ADR, there was a three percent decrease in colorectal cancer risk. That study, published in The New England Journal of Medicine, said the ADR “was inversely associated with the risks of interval colorectal cancer, advanced-stage interval cancer, and fatal interval cancer.”

The Polish study also concluded high-quality colonoscopies are perhaps even more important for women. “Examination quality particularly affected CRC incidence and mortality in women,” the researchers said. “After low-quality colonoscopy, incidence rates in women were significantly higher than the rates observed in men throughout follow-up.”

In 2019, AMSURG ambulatory surgery centers (ASCs) completed more than 938,000 colonoscopies and identified nearly 360,000 patients with adenomas/cancers. The ADR for AMSURG clinicians participating in GIQuIC is 38.37 percent – nearly double the ADR the Polish study rated as high-quality. (About three-quarters of all AMSURG ASCs participate in GIQuIC.)

“In 2019 AMSURG clinicians identified more than 125,000 additional cancers and adenomas than would be expected if their ADR was simply equal to the national benchmark,” said Dr. Jay Popp, AMSURG Medical Staff Development Lead. “When it comes to colonoscopies, quality can be a life or death matter. By tracking ADR through GIQuIC, our centers provide the information patients need to make informed decisions that will reduce their risk of developing colorectal cancer and will protect their long-term health.”

AMSURG and Mount Sinai Health System Release New Research on Early-Onset Colorectal Cancer

by

Findings Support Recommendations to Lower Average Screening Age to 45

(NEW YORK, NY & NASHVILLE, TN – May 24, 2021) — AMSURG, a division of Envision Healthcare and a national leader in outpatient care, and Icahn School of Medicine at Mount Sinai, world-renowned for its groundbreaking research, released new findings on colorectal cancer (CRC), which support several recommendations to lower the screening age from 50 to 45 for people who are at average risk for CRC. The findings were presented at the Digestive Disease Week® 2021 virtual scientific meeting on May 23.

The Mount Sinai team analyzed approximately 3 million colonoscopies performed at more than 120 AMSURG ambulatory surgery centers across the country in the last six years. The study specifically looked at de-identified data from patients aged 18 to 54 who received a screening or diagnostic colonoscopy and were not undergoing a colonoscopy to monitor previously detected polyps, cancer, inflammatory bowel disease or genetic conditions predisposing to cancer. Results show:

  • Colorectal cancer was detected in 0.58 percent of patients aged 45 to 49 and in 0.53 percent of patients aged 40 to 44
  • Polyps that had the greatest possibility of becoming cancerous were found in 7.5 percent of patients aged 45 to 49 and in 5.8 percent of patients aged 40 to 44
  • A significant portion of patients had polyps present even if they did not have a documented family history of colorectal cancer

“These findings are significant and can make a meaningful difference in the healthcare system's ability to save patients’ lives. With early and routine colonoscopies, we can prevent polyps from becoming cancerous and even detect and remove cancerous polyps while giving patients a better chance of recovery and survival. These data support efforts to begin screening at age 45 and communicate the importance of on-time screening by early messaging to patients and providers,” said John Popp, MD, Medical Director for AMSURG.

Colorectal cancer is the second leading cause of cancer death in the U.S. and one of the most preventable. The incidence of CRC in patients under 50 has nearly doubled since the early 1990s.[1] Consensus in the medical community is building that patients who are at average risk for CRC should begin screening at age 45.

“This study can inform additional research directed at CRC screening in younger populations. More importantly, it helps physicians inform patients about the importance of early screening several years before they reach screening age; we believe that this will encourage younger patients to get routine screenings on time, at the appropriate age, and with close attention to the individual’s risk factors and symptoms,” said primary investigator, Steven Itzkowitz, MD, Professor of Medicine, Oncological Sciences and Medical Education, and Director of the GI Fellowship Program at Icahn School of Medicine at Mount Sinai.

Risk factors include a family history of CRC or pre-malignant polyps, inflammatory bowel disease and lifestyle habits, such as diet, smoking and obesity. CRC also disproportionately impacts the Black community. While symptoms are not always easy to recognize, they can include a change in bowel habits, such as diarrhea and constipation. Additionally, rectal bleeding, abdominal discomfort or a feeling that the bowel does not completely empty can be a cause for concern. Individuals are urged to listen to their bodies and consult their physicians if they have questions or require medical care. 

As a leading provider of colonoscopies, AMSURG submits a larger colonoscopy dataset than any provider to a national endoscopic registry called the GI Quality Improvement Consortium (GIQuIC).
The AMSURG data reviewed for this study was obtained from the registry.

This research on CRC trends in the United States is the first of an ongoing collaboration between AMSURG and Mount Sinai.

###

About AMSURG
AMSURG acquires, develops and operates ambulatory surgery centers (ASC) in partnership with physicians throughout the United States. As of January 1, 2021, AMSURG operates and holds ownership in more than 250 ASCs in 34 states and the District of Columbia with medical specialties ranging from gastroenterology to ophthalmology and orthopaedics. To learn more about AMSURG, a division of Envision Healthcare Corporation, visit www.amsurg.com.

About Envision Healthcare Corporation
Envision Healthcare Corporation is a leading national medical group that delivers physician and advanced practice provider services, primarily in the areas of emergency and hospitalist medicine, anesthesiology, radiology/teleradiology, and neonatology to more than 1,800 clinical departments in healthcare facilities in 45 states and the District of Columbia. Post-acute care is delivered through an array of clinical professionals and integrated technologies which, when combined, contribute to efficient and effective population health management strategies.

As a leader in ambulatory surgical care, the medical group operates and holds ownership in more than 250 surgery centers in 34 states and the District of Columbia, with medical specialties ranging from gastroenterology to ophthalmology and orthopaedics. In total, the medical group offers a differentiated suite of clinical solutions on a national scale with a local understanding of our communities, creating value for health systems, payers, providers, and patients. For additional information, visit www.envisionhealth.com.

About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

1 Stoffel EM, Murphy CC. Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults. Gastroenterology. 2020;158(2):341-353.